# Effects of Glucagon Administration on Energy Expenditure

> **NCT02237053** · PHASE1 · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 6 (actual)

## Conditions studied

- Hyperglucagonemia
- Obesity

## Interventions

- **DRUG:** Glucagon
- **DRUG:** Octreotide
- **BEHAVIORAL:** Placebo
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT02237053
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237053, "Effects of Glucagon Administration on Energy Expenditure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02237053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*